Amerisource Health Services LLC recalls
16 notices naming Amerisource Health Services LLC as the recalling firm, since December 11, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Contamination
Amerisource Health Services LLC: Primidone Tablets and 1 more
Hazard (FDA): Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
FDAMedicines
Amerisource Health Services LLC: Meclizine Hydrochloride Tablets
Hazard (FDA): Failed tablet specifications.
FDAMedicines
Amerisource Health Services LLC: Oxycodone Hydrochloride Tablets
Hazard (FDA): Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
FDAMedicines
Potency
Amerisource Health Services LLC: Prazosin Hydrochloride and 2 more
Hazard (FDA): Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
FDAMedicines
Amerisource Health Services LLC: Sucralfate Tablets
Hazard (FDA): CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity…
FDAMedicines
Dissolution
Amerisource Health Services LLC: Carbamazepine Extended-Release Tablets
Hazard (FDA): Failed Dissolution Specifications.
FDAMedicines
Amerisource Health Services LLC: chlorproMAZINE Hydrochloride Tablets and 3 more
Hazard (FDA): Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any…
FDAMedicines
Amerisource Health Services LLC: Sucralfate Tablets
Hazard (FDA): CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity…
FDAMedicines
Amerisource Health Services LLC: Indomethacin Extended-Release Capsules
Hazard (FDA): cGMP deviations
FDAMedicines
Sterility
Amerisource Health Services LLC: Haloperidol Decanoate Injection and 2 more
Hazard (FDA): Lack of assurance of sterility. Bacterial contamination detected in some media fill units
FDAMedicines
Amerisource Health Services LLC: Voriconazole Tablets
Hazard (FDA): cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
FDAMedicines
Amerisource Health Services LLC: Clobazam Tablets
Hazard (FDA): Presence of Foreign Tablets/Capsules
FDAMedicines
Dissolution
Amerisource Health Services LLC: glipiZIDE
Hazard (FDA): Failed Dissolution Specifications:
FDAMedicines
Amerisource Health Services LLC: Clobazam Tablets
Hazard (FDA): Presence of Foreign Tablets/Capsules
FDAMedicines
Amerisource Health Services LLC: Duloxetine Delayed-Release Capsules USP and 3 more
Hazard (FDA): CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
FDAMedicines
Amerisource Health Services LLC: Duloxetine Delayed-Release Capsules and 2 more
Hazard (FDA): CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
FDAMedicines